What the FDA’s 2026 Peptide Reviews Say About Seven Research Compounds
FDA published substance reviews for seven research peptides in July 2026. What they found on human data for BPC-157, KPV, MOTS-c and more.
Archive
Tag: BPC-157 Canada
Articles on BPC-157 research, safety data and regulatory status in Canada.
TB-500 vs TB-500 Fragment: What’s Actually in the Vial
The FDA registers TB-500 as a seven-residue fragment, not full-length thymosin beta-4. Why only a measured mass tells the two vials apart.
The MAPK Pathway Explained: Ras, RAF, MEK and ERK
How the three-tier Ras-RAF-MEK-ERK cascade works, why signal duration rather than signal presence decides cell fate, why a pathway inhibitor can switch the pathway on, and which research compounds genuinely have published ERK data.
Peptides in Canada: 24 Questions Canadians Ask on Reddit, Answered
Are peptides legal in Canada? Will customs seize an overseas order? Are COAs faked? Straight, sourced answers to the 24 peptide questions Canadians ask most on Reddit.
Angiogenesis and VEGF Explained: How New Blood Vessels Form
VEGF and angiogenesis explained: how new blood vessels form, the VEGF receptors, why cancer drugs block it, and the peptide research angle.
KLOW Peptide Blend: What’s Inside and What the Research Shows
KLOW peptide explained: the GHK-Cu, BPC-157, TB-500 and KPV blend, what each component's research shows, KLOW vs GLOW, and how to verify a blend COA in Canada.
BPC-157 Safety: What Toxicology, Human Data and Regulators Say
Is BPC-157 safe? What animal toxicology, the three small human pilot studies, the cancer question and 2026 decisions by Health Canada and the FDA actually show.
